The genetic risk of acute lymphoblastic leukemia and its implications for children of Latin American origin

Front Oncol. 2024 Jan 9:13:1299355. doi: 10.3389/fonc.2023.1299355. eCollection 2023.

Abstract

Acute lymphoblastic leukemia (ALL) is the most common cancer in children, and disproportionately affects children of Hispanic/Latino ethnicity in the United States, who have the highest incidence of disease compared with other racial/ethnic groups. Incidence of childhood ALL is similarly high in several Latin American countries, notably in Mexico, and of concern is the rising incidence of childhood ALL in some Hispanic/Latino populations that may further widen this disparity. Prior studies have implicated common germline genetic variants in the increased risk of ALL among Hispanic/Latino children. In this review, we describe the known disparities in ALL incidence as well as patient outcomes that disproportionately affect Hispanic/Latino children across the Americas, and we focus on the role of genetic variation as well as Indigenous American ancestry in the etiology of these disparities. Finally, we discuss future avenues of research to further our understanding of the causes of the disparities in ALL incidence and outcomes in children of Latin American origin, which will be required for future precision prevention efforts.

Keywords: ALL; Hispanic/Latino; Latin America; childhood acute lymphoblastic leukemia; disparities; genetic epidemiology; genetics; single nucleotide polymorphisms.

Publication types

  • Review